Advancing new potential treatments for certain GI diseases affecting millions of patients in need
Represents current phase of development, does not correspond to the initiation or completion of a particular phase.
Status of key development programs as of February 28, 2019.
Copyright © 2019, Ironwood Pharmaceuticals, Inc. All Rights Reserved
LINZESS®, CONSTELLA®, IRONWOOD® and their associated logos are trademarks of Ironwood Pharmaceuticals, Inc. Any other trademarks referred to herein are the property of their respective owners. All rights reserved.